Besides, IKKβ/NEMO-dependent anti-tumor efficacy of SHK was also validated in an LoVo/IKKβmut (D738A/W739A/W741A, three points co-mutation) xenograft mouse model. The gene discussed is SHPK; the disease is neoplasm.